296 related articles for article (PubMed ID: 30616802)
21. A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.
Vargo JA; Ward MC; Caudell JJ; Riaz N; Dunlap NE; Isrow D; Zakem SJ; Dault J; Awan MJ; Higgins KA; Hassanadeh C; Beitler JJ; Reddy CA; Marcrom S; Boggs DH; Bonner JA; Yao M; Machtay M; Siddiqui F; Trotti AM; Lee NY; Koyfman SA; Ferris RL; Heron DE
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):595-605. PubMed ID: 28899556
[TBL] [Abstract][Full Text] [Related]
22. [Reirradiation for head and neck squamous cell carcinoma: Indications and results].
Biau J; Moreau J; Blanchard P; Thariat J; Miroir J; Lapeyre M
Cancer Radiother; 2019 Oct; 23(6-7):559-564. PubMed ID: 31451359
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group.
Orlandi E; Bonomo P; Ferella L; D'Angelo E; Maddalo M; Alterio D; Infante G; Bacigalupo A; Argenone A; Iacovelli NA; Desideri I; Meduri B; Triggiani L; Volpe S; Belgioia L; Dionisi F; Romanello DA; Fallai C; Miceli R
Head Neck; 2019 Oct; 41(10):3684-3692. PubMed ID: 31355972
[TBL] [Abstract][Full Text] [Related]
24. Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
Choe KS; Haraf DJ; Solanki A; Cohen EE; Seiwert TY; Stenson KM; Blair EA; Portugal L; Villaflor VM; Witt ME; Vokes EE; Salama JK
Cancer; 2011 Oct; 117(20):4671-8. PubMed ID: 21671479
[TBL] [Abstract][Full Text] [Related]
25. A pre-operative prognostic score for the selection of patients for salvage surgery after recurrent head and neck squamous cell carcinomas.
Lupato V; Polesel J; La Torre FB; Fanetti G; Fratta E; Gobitti C; Baldassarre G; Vaccher E; Franchin G; Giacomarra V
Sci Rep; 2021 Jan; 11(1):502. PubMed ID: 33436706
[TBL] [Abstract][Full Text] [Related]
26. Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy.
McDonald MW; Zolali-Meybodi O; Lehnert SJ; Estabrook NC; Liu Y; Cohen-Gadol AA; Moore MG
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):808-819. PubMed ID: 27788954
[TBL] [Abstract][Full Text] [Related]
27. The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate-risk HPV-negative HNSCC.
Tasoulas J; Lenze NR; Farquhar D; P Schrank T; Shen C; Shazib MA; Singer B; Patel S; Grilley Olson JE; Hayes DN; Gulley ML; Chera BS; Hackman T; Olshan AF; Weiss J; Sheth S
Cancer Med; 2021 May; 10(10):3231-3239. PubMed ID: 33934525
[TBL] [Abstract][Full Text] [Related]
28. Reirradiation for second primary or recurrent cancers of the head and neck: Dosimetric and outcome analysis.
Garg S; Kilburn JM; Lucas JT; Randolph D; Urbanic JJ; Hinson WH; Kearns WT; Porosnicu M; Greven K
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E961-9. PubMed ID: 25993910
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in patients with recurrent head and neck cancer treated with reirradiation.
Krstevska V; Tolevska C; Zafirova-Ivanova B; Stojkovski I; Crvenkova S
J BUON; 2008; 13(3):369-76. PubMed ID: 18979552
[TBL] [Abstract][Full Text] [Related]
30. Surgery or Radiotherapy of the Primary Tumor in T1-2 Head and Neck Squamous Cell Carcinoma with Resectable N3 Nodes: A Multicenter GETTEC Study.
Carsuzaa F; Thariat J; Gorphe P; Righini C; Cosmidis A; Thureau S; Roge M; De Mones E; Servagi-Vernat S; Tonnerre D; Morinière S; Dugas A; Malard O; Pasquier F; Vergez S; Salleron J; Dufour X
Ann Surg Oncol; 2019 Oct; 26(11):3673-3680. PubMed ID: 31264120
[TBL] [Abstract][Full Text] [Related]
31. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
[TBL] [Abstract][Full Text] [Related]
32. Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach-part I: prognostic factors and indications to treatment.
Alterio D; Zaffaroni M; Bossi P; Dionisi F; Elicin O; Falzone A; Ferrari A; Jereczek-Fossa BA; Sanguineti G; Szturz P; Volpe S; Scricciolo M
Radiol Med; 2024 Jan; 129(1):160-173. PubMed ID: 37731151
[TBL] [Abstract][Full Text] [Related]
33. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
[TBL] [Abstract][Full Text] [Related]
34. A review on re-irradiation for recurrent and second primary head and neck cancer.
Kasperts N; Slotman B; Leemans CR; Langendijk JA
Oral Oncol; 2005 Mar; 41(3):225-43. PubMed ID: 15743686
[TBL] [Abstract][Full Text] [Related]
35. Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate radiotherapy: An institutional series.
Megahed R; Prabhu AV; Mack DP; Gholami S; Samanta S; Patel M; Lewis GD
Oral Oncol; 2024 May; 152():106778. PubMed ID: 38555751
[TBL] [Abstract][Full Text] [Related]
36. Retrospective analysis of treatment outcomes following reirradiation in locoregionally recurrent head and neck cancer patients: A single institutional study.
Kakria A; Rawat S; Bhutani R; Gupta G; Devnani B; Wahi IK; Ahlawat P
Asia Pac J Clin Oncol; 2015 Jun; 11(2):129-34. PubMed ID: 25132076
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer.
Sher DJ; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Balboni T; Allen A; Tishler RB
Cancer; 2010 Oct; 116(20):4761-8. PubMed ID: 20572036
[TBL] [Abstract][Full Text] [Related]
38. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
[TBL] [Abstract][Full Text] [Related]
39. Outcome in patients with isolated regional recurrence after primary radiotherapy for head and neck cancer.
Lindegaard AM; von Buchwald C; Rasmussen JH; Specht L; Vogelius IR; Zamani M; Woller NC; Lelkaitis G; Friborg J
Head Neck; 2020 Nov; 42(11):3161-3170. PubMed ID: 32681703
[TBL] [Abstract][Full Text] [Related]
40. Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory.
Duprez F; Madani I; Bonte K; Boterberg T; Vakaet L; Derie C; De Gersem W; De Neve W
Radiother Oncol; 2009 Dec; 93(3):563-9. PubMed ID: 19919885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
